Concepedia

Kiyotomo Seto

KS

Statistics

Publications

4

Citations

193

H-Index

4

Active since

1980

Affiliations

Nissan Chemical Corporation (Japan)(Current)

Kagoshima University

Kiyotomo Seto is an author at Nissan Chemical Corporation (Japan) specializing in cancer pharmacology, anticancer drug resistance, and chemotherapy resistance.

Publications per year

1980–2000

4

Publications

4

Reversal of LRP-associated drug resistance in colon carcinoma sw-620 cells

Masaki Kitazono, Hiroshi Okumura, Ryuji Ikeda et al. · International Journal of Cancer · 2000 · 71 citations · Full text

, , +14

Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.

M. Kamiwatari, Yukihiro Nagata, Hiroshi Kikuchi et al. · PubMed · 1989 · 55 citations

, , +16

The oxidation of adamantane with an iron salen complex modelling ω-hydroxylase

Iwao Tabushi, Toshio Nakajima, Kiyotomo Seto · Tetrahedron Letters · 1980 · 41 citations

, , +12

Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P

Yutaka Chuman, Zhe‐Sheng Chen, Kiyotomo Seto et al. · Cancer Letters · 1998 · 26 citations

, , +10

1–4 of 4